|Videos|October 12, 2021

Addressing Influenza in the COVID-19 Era

Author(s)Tina Q. Tan, M.D., FAAP, FIDSA, FDIPS, John J Russell, MD, FAAFP, Stephan Foster, PharmD, FAPhA, FNAP

A group of experts led by Tina Q. Tan, MD, FAAP, FIDSA, FDIPS, discuss how best to address influenza prevention, identification, and treatment in the COVID-19 era and beyond.

Stay informed with the Medical Economics eNewsletter, delivering expert insights, financial strategies, practice management tips, and technology trends tailored for today’s physicians.

Latest CME

Video

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

Trending on Medical Economics

Physicians finally got a Medicare raise. Keeping it is the hard part.

Medtronic acquires neurovascular access device maker Scientia Vascular for $550M

The new front door to health care, with Andrea Giamalva, M.D., FAAFP, of Experity

When prior authorization sparks ‘outrage and frustration’

ADA ousts researchers then apologizes; Medicare Advantage reverses 95% of appealed denials; AMA takes on AI and corporate medicine — Morning Medical Update Weekly Recap

Addressing Influenza in the COVID-19 Era

Related Content

Practice size: How many doctors are in the office?

Maternal mortality; brain implant research; $30M in phony claims for COVID-19 tests – Morning Medical Update

More than 90% of docs feeling burned out: survey

Doctors must have robust online presence to meet today’s patients’ expectations

Responding to patient requests for a second opinion